SCHEMBL229948

SCHEMBL229948

[CH2]C(CC)C(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27991561 0.97
SCHEMBL1362150 0.80
SCHEMBL16500125 0.78
SCHEMBL3885820 0.78
SCHEMBL6728521 0.76
SCHEMBL83901 0.76
SCHEMBL27991565 0.76 ALDH1A1 (0.30)
SCHEMBL828954 0.74
SCHEMBL3892557 0.74
SCHEMBL5429936 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130087745-A1 SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS PRECURSOR ENERGETICS, INC. (US) 2013-04-11 US claimed
WO-2008084046-A1 PLASTICIZERS FOR POLYVINYL ACETALS AND POLYSULFIDES BASF SE (DE) 2008-07-17 WO claimed
US-5223576-A Blend of polyphenylene ether and unsaturated polymer; high strength, solvent resistant MITSUBISHI PETROCHEMICAL COMPANY, LTD. (JP) 1993-06-29 US claimed
US-20240191009-A1 POLYFUNCTIONALIZED HIGH-CIS 1,4-POLYBUTADIENE AND METHOD FOR MANUFACTURING THE SAME KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2024-06-13 US disclosed
US-20240174947-A1 SURFACTANT COMPOSITIONS LANKEM LTD. (GB) 2024-05-30 US disclosed
EP-4373529-A1 FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF 3B Pharmaceuticals GmbH (DE) 2024-05-29 EP disclosed
US-20240115745-A1 COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2024-04-11 US disclosed
CN-113164361-B Personal care compositions 高露洁-棕榄公司 2024-04-02 CN disclosed
CN-117769443-A Fibroblast activation protein inhibitor and use thereof 3B制药有限公司 2024-03-26 CN disclosed
WO-2024053609-A1 ALKALI-SOLUBLE RESIN, METHOD FOR PRODUCING SAME, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, MEMBER FOR DISPLAY DEVICE, AND DISPLAY DEVICE 株式会社日本触媒 2024-03-14 WO disclosed
WO-2024052431-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2024-03-14 WO disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed
US-4791128-A Rhizoxin esters and salts, their pharmaceutical use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1988-12-13 US disclosed
US-4683224-A INSECTICIDES, MITICIDES, NEMATOCIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-07-28 US disclosed
CN-86106331-A N-formyl radical sulfo-phosphonic amide ester 1987-06-03 CN disclosed
EP-0218310-A2 Rhizoxin derivatives, their preparation and pharmaceutical use SANKYO COMPANY LIMITED (JP) 1987-04-15 EP disclosed
CN-86102020-A The preparation method of rhizoxin derivatives and in pharmaceutically application 1986-10-01 CN disclosed
US-4120947-A Xanthine compounds and method of treating bronchospastic and allergic diseases COOPER LABORATORIES, INC. (US) 1978-10-17 US disclosed
US-4089959-A Long-acting xanthine bronchodilators and antiallergy agents COOPER LABORATORIES, INC. (US) 1978-05-16 US disclosed
US-3959387-A Recovery of brominated biphenyl oxide ETHYL CORPORATION (US) 1976-05-25 US disclosed